Clear Lensectomy with Hydrus Stent in Black and Afro-Latino Patients: A 1-Year Retrospective Study
Table 4
Intraocular pressure and number of medications at preoperative and follow-up visits for patients with primary open-angle and angle-closure glaucoma who underwent clear lensectomy in combination with Hydrus microstent implant.
Timepoint
POAG (N = 103)
ACG (N = 24)
IOP (mean ± SD; mmHg)
value
Number of medications (mean ± SD)
value
Mean deviation ± SD (dB)
IOP (mean ± SD; mmHg)
value
Number of medications (mean ± SD)
value
Mean deviation ± SD (dB)
Preoperative
14 ± 3.5
—
2.5 ± 1.4
—
−9.02 ± 7.56
15.75 ± 5.2
—
2.62 ± 1.20
—
−6.65 ± 5.53
Postoperative day 1
12.1 ± 4.9
<0.001
—
—
10.4 ± 2.5
<0.001
—
—
1 month
14.7 ± 4.7
0.22
0.16 ± 0.72
<0.001
14.5 ± 6.1
0.44
0
<0.001
3 months
12.8 ± 2.6
0.007
0.37 ± 0.94
<0.001
13.6 ± 3.7
0.12
0.57 ± 1.0
<0.001
6 months
13.0 ± 2.7
0.02
0.33 ± 0.89
<0.001
13.3 ± 3.5
0.06
0.86 ± 1.4
<0.001
1 year
13.8 ± 3.06
0.66
0.34 ± 0.92
<0.001
−8.69 ± 7.80 ()
13.2 ± 2.9
0.04
0.91 ± 1.5
<0.001
−7.88 ± 7.58 (P = 0.53)
ACG, angle-closure glaucoma; IOP, intraocular pressure; N, number of patients; POAG, primary open-angle glaucoma; SD, standard deviation. values are statistically significant.
